The announcement by NYU Langone’s Board of Trustees was praised by Kenneth Langone, board chair and co-chair of the search ...
NYU Langone Health tapped Alec Kimmelman to succeed Robert Grossman as its next CEO and dean of the NYU Grossman School of ...
Joanne Liu says her alma mater’s health system pulled her talk, which included discussions of funding cuts to humanitarian ...
A new study led by scientists at NYU Langone Health sheds light on how the major cancer gene BRCA2 determines which cancer cells can be killed by a class of precision cancer drugs called PARP ...
New York City based NYU Langone Health has selected Alec Kimmelman, MD, PhD, as the next CEO and dean of NYU Grossman School of Medicine, effective Sept. 1. Dr. Kimmelman, a researcher and radiation ...
News Medical on MSN10h
Study sheds light on how major cancer gene influences the success of PARP inhibitorsA study led by scientists at NYU Langone Health sheds light on how the major cancer gene BRCA2 determines which cancer cells can be killed by a class of precision cancer drugs called PARP inhibitors.
16h
Dr. Doris Day, a board-certified dermatologist, has barely any wrinkles at 62. She has had cosmetic treatments, but said that ...
A new study led by scientists at NYU Langone Health sheds light on how the major cancer gene BRCA2 determines which cancer cells can be killed by a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback